NASDAQ:NBRV
Nabriva Therapeutics plc
- Stock
locale
Ireland
market
STOCKSindustry
Biotechnologywebsite
www.nabriva.comipo date
Jun 23, 2017
Nabriva Therapeutics plc, a biopharmaceutical company, engages in the development and commercialization of novel anti-infective agents to treat serious infections. The company's product includes SIVEXTRO, an oxazolidinone-class antibacterial for the treatment of acute bacterial skin and skin structure infection (ABSSSI); and XENLETA, a semi-synthetic pleuromutilin antibiotic fo...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus